Literature DB >> 23750858

Evaluation of the contribution of the ATP binding cassette transporter, P-glycoprotein, to in vivo cholesterol homeostasis.

Stephen D Lee1, Sheila J Thornton, Kristina Sachs-Barrable, Jenny H Kim, Kishor M Wasan.   

Abstract

P-glycoprotein (Pgp, encoded by ABCB1, commonly known as MDR1), an ATP-dependent transporter with a broad range of hydrophobic drug substrates, has been associated with the in vitro intracellular transport of cholesterol; however, these findings have not been confirmed in vivo. In this manuscript we tested the contributions of Pgp to in vivo cholesterol homeostasis by comparing the cholesterol phenotype of wild type mice with mice lacking both murine isoforms of Pgp (Abcb1a(-/-)/1b(-/-)) by measuring cholesterol absorption, circulating cholesterol, and lipoprotein cholesterol profiles. The mice were fed diets containing normal or high levels of dietary fat (25% vs 45% kcal from fat) and cholesterol (0.02% vs 0.20% w/w) for 8 weeks to challenge their capacity to maintain homeostasis. There were no significant differences in cholesterol absorption, circulating cholesterol levels, and lipoprotein profiles between Pgp knockout and wild type mice fed matching diets. Compensatory shifts were observed in the activation of two key transcription factors involved in maintaining cholesterol balance, the Liver X Receptor and SREBP-2, which may have maintained the wild type phenotype in the knockout mice. Deletion of Pgp affected the molar composition of gallbladder bile, when the mice were fed diets containing high levels of dietary fat, cholesterol, or both. The mole fraction of bile salts was reduced in the gallbladder bile of Pgp knockout mice, while the mole fraction of cholesterol was increased. In this paper, we provide evidence that Pgp knockout mice maintain cholesterol homeostasis, even when challenged with high cholesterol diets. We suggest that the specific shifts in cholesterol regulatory networks identified in the jejunum and liver of the knockout mice may have compensated for the lack of Pgp. Our finding that Pgp knockout mice were unable to maintain gallbladder bile composition when challenged with high dietary fat and/or cholesterol compliments recent reports that Pgp may be a secondary bile salt export pump.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750858      PMCID: PMC5104543          DOI: 10.1021/mp4002415

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  53 in total

1.  Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance.

Authors:  S VanPatten; N Ranginani; S Shefer; L B Nguyen; L Rossetti; D E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

2.  Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels.

Authors:  Liam R Brunham; Janine K Kruit; Terry D Pape; John S Parks; Folkert Kuipers; Michael R Hayden
Journal:  Circ Res       Date:  2006-08-31       Impact factor: 17.367

3.  Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins.

Authors:  Michele K Wu; David E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-08-11       Impact factor: 4.052

Review 4.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans.

Authors:  J M Dietschy; S D Turley; D K Spady
Journal:  J Lipid Res       Date:  1993-10       Impact factor: 5.922

5.  Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver.

Authors:  S D Turley; B P Daggy; J M Dietschy
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

6.  Progesterone inhibits cholesterol biosynthesis in cultured cells. Accumulation of cholesterol precursors.

Authors:  J E Metherall; K Waugh; H Li
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

7.  Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump.

Authors:  Renxue Wang; Huey-Ling Chen; Lin Liu; Jonathan A Sheps; M James Phillips; Victor Ling
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

8.  The diet and 15-year death rate in the seven countries study.

Authors:  A Keys; A Menotti; M J Karvonen; C Aravanis; H Blackburn; R Buzina; B S Djordjevic; A S Dontas; F Fidanza; M H Keys
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

9.  The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse.

Authors:  Janan T Eppig; Judith A Blake; Carol J Bult; James A Kadin; Joel E Richardson
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

10.  Effect of dietary fat on hepatic liver X receptor expression in P-glycoprotein deficient mice: implications for cholesterol metabolism.

Authors:  Sheila J Thornton; Evelyn Wong; Stephen D Lee; Kishor M Wasan
Journal:  Lipids Health Dis       Date:  2008-06-11       Impact factor: 3.876

View more
  4 in total

1.  Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.

Authors:  Jin Chai; Xiaohuang Du; Sheng Chen; XinChan Feng; Ying Cheng; Liangjun Zhang; Yu Gao; Shaoxue Li; Xiaochong He; Rongquan Wang; Xiangdong Zhou; Yong Yang; Weizao Luo; Wensheng Chen
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.

Authors:  Xin-Chan Feng; Xiaohuang Du; Sheng Chen; Dongmei Yue; Ying Cheng; Liangjun Zhang; Yu Gao; Shaoxue Li; Lei Chen; Zhihong Peng; Yong Yang; Weizao Luo; Rongquan Wang; Wensheng Chen; Jin Chai
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 3.  Liver X receptors at the intersection of lipid metabolism and atherogenesis.

Authors:  Stephen D Lee; Peter Tontonoz
Journal:  Atherosclerosis       Date:  2015-07-02       Impact factor: 5.162

4.  Serum 4β-hydroxycholesterol increases during fluconazole treatment.

Authors:  Dieter Lütjohann; Frans Stellaard; Anja Kerksiek; Jörn Lötsch; Bruno G Oertel
Journal:  Eur J Clin Pharmacol       Date:  2020-11-17       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.